Shares of RPG Life Sciences rose 7.64% to ₹2,277.60 on today, climbing ₹161.70 from the previous close of ₹2,115.90. The stock was among the top gainers on the NSE following the announcement of the company’s Q4 FY24 financial results.
RPG Life Sciences reported a net profit of ₹117.35 crore for the quarter ended March 2024, marking a sharp increase of 786% from ₹13.24 crore in the corresponding period of the previous year. This substantial profit growth was attributed to a one-time gain of ₹109.90 crore, linked to the assignment of surplus leasehold land with built-up structures in Navi Mumbai.
Revenue from operations during the quarter stood at ₹143.09 crore, registering a 13% increase year-on-year compared to ₹126.99 crore. EBITDA also improved significantly, rising 115% to ₹30.55 crore, with margins expanding to 21%, up from 11% in Q4 FY23.
The company also announced a final dividend of ₹20 per share and a special dividend of ₹4 per share, citing the exceptional profit from land monetisation. These dividends are subject to shareholder approval at the upcoming annual general meeting.
At the time of reporting, RPG Life Sciences’ market capitalisation stood at ₹37,640 crore with a P/E ratio of 47.55.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
